Integra LifeSciences Recalls Codman Disposable Perforators

by Pill Pals Customer Service | Jul 16, 2025 | News

This recall involves removing certain devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it.Affected ProductProduct NameUnique Device Identifier...

Determining the Contribution of the Individual Drugs’ Effects

by Pill Pals Customer Service | Jul 16, 2025 | News

Submit Comments by 09/15/2025 Although you can comment on any guidance at any time (see 21 CFR 10.115(g)(5)), to ensure that the FDA considers your comment on a draft guidance before it begins work on the final version of the guidance, submit either online or written...

FDA and Kratom

by Pill Pals Customer Service | Jul 15, 2025 | News

FDA recognizes that there is much that is not known scientifically about kratom. Although there are published animal studies with kratom extracts containing mitragynine or 7-OH-mitragynine, there are few published reports from well-designed scientific studies where...

Drug Trials Snapshot: VANRAFIA

by Pill Pals Customer Service | Jul 15, 2025 | News

HOW TO USE THIS SNAPSHOTThe information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, and whether there were differences among sex, race, age, and ethnic groups. The “MORE INFO” bar...

Krasniy Oktyabr Inc. USA Issues Alert on Eviscerate Dry Salted Vobla “Aral Silver”

by Pill Pals Customer Service | Jul 15, 2025 | News

Summary Company Announcement Date: July 15, 2025 FDA Publish Date: July 15, 2025 Product Type: Food & Beverages Foodborne Illness Reason for Announcement: Recall Reason Description Potential Foodborne Illness – Clostridium botulinum Company Name: KRASNIY OKTYABR...

Mark J. Savant, M.D./San Francisco Research Institute – 712306

by Pill Pals Customer Service | Jul 15, 2025 | News

Delivery Method: VIA UNITED PARCEL SERVICE AND VIA E-MAIL Reference #: 25-HFD-45-06-02 Product: Drugs Recipient: Mark J. Savant, M.D./San Francisco Research Institute 2435 Ocean AvenueSan Francisco, CA 94127United States Issuing Office: Center for Drug Evaluation and...